News in Numbers

The World Health Organization (WHO) and several multilateral banks have kicked off the Health Impact Investment Platform to unlock €1.5bn in loans and grants to expand and improve healthcare services in low- and middle-income countries.

UNICEF has reached an agreement with mpox vaccine manufacturer Bavarian Nordic to supply one million doses of the shot for the hardest-hit countries in Africa.

Bicara Therapeutics raised $362m in gross proceeds from its initial public offering (IPO) as it entered the stock market.

Sanofi is eyeing global regulatory approval for multiple sclerosis (MS) drug tolebrutinib after trial results showed that it delayed the time to six-month disability progression by 31% compared to placebo.

Epigenetic drugs show have seen a 375% increase in Series A venture financing in 2024.